This inventor holds 3 USPTO granted patents. Top assignees: Ge Precision Healthcare LLC, General Electric Company. Active years: 2021-2025.
Company Filing History:
Years Active: 2021-2025
Title: Melodie Sperandio: Innovator in Computer-Aided Diagnosis
Introduction
Melodie Sperandio is a notable inventor based in Buc, France. She has made significant contributions to the field of medical technology, particularly in the area of computer-aided diagnosis systems for prostate cancer. With a total of three patents to her name, her work is paving the way for advancements in healthcare diagnostics.
Latest Patents
One of Melodie Sperandio's latest patents focuses on multi-modal computer-aided diagnosis systems and methods for prostate cancer. This invention includes methods and apparatus for diagnosing prostate conditions using advanced imaging techniques. The apparatus is designed with memory to store instructions and a processor capable of detecting lesions from images of the prostate gland. It generates a mapping of the lesion to a sector map, identifying the depth region of the lesion along a depth axis. This innovative approach provides a detailed representation of the lesion within the prostate gland, enhancing the accuracy of diagnoses.
Career Highlights
Throughout her career, Melodie has worked with prominent companies in the healthcare sector. She has been associated with GE Precision Healthcare LLC and General Electric Company, where she has contributed her expertise in medical technology and innovation. Her work has been instrumental in developing systems that improve patient outcomes through better diagnostic tools.
Collaborations
Melodie has collaborated with talented professionals in her field, including Lucile Nosjean and Lorraine Jammes. These collaborations have fostered an environment of innovation and creativity, leading to advancements in medical technology.
Conclusion
Melodie Sperandio is a pioneering inventor whose work in computer-aided diagnosis systems is making a significant impact in the field of healthcare. Her patents and collaborations reflect her commitment to improving diagnostic methods for prostate cancer, ultimately benefiting patients and healthcare providers alike.